vasculostatin-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-vasculostatin(Cat#: CyOV-0008XY)
DatasheetThis product is a vasculostatin expressing oncolytic herpes simplex virus, which is based on HSV-1 with ICP27 deleted. ICP27 is highly cytotoxic probably due to its secondary role of preventing the splicing of pre-mRNAs in favour of translation from the mainly unspliced hepes RNAs. Deletion of ICP27 might produce a safer and less cytotoxic system when combined with other oncolytic-rendered modifications. This product can be used in oncolytic virotherapy research and further recombinant HSV construction.
Specifications | |
|---|---|
| Family | Herpesviridae |
| Species | Herpes simplex virus |
| Serotype | Herpes simplex virus 1 |
| Backbone | HSV-1 (ΔICP27) |
| Backbone Background | Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as human herpesvirus 1 and 2 (HHV-1 and HHV-2), are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Modified Herpes simplex virus is considered as a potential therapy for cancer and has been extensively clinically tested to assess its oncolytic ability. |
| Gene Modification | ΔICP27 |
| Promoter | CMV |
| Transgene | vasculostatin |
| Type of Transgene | Cytokine |
| Related Target/Protein | Vasculostatin |
| Capsid Modification | None |
| Titer | >1*10^8 PFU |
| Related Diseases | Tumor |
Transgene | |
|---|---|
| Alternative Names | vasculostatin |
Information | |
|---|---|
| Introduction | Vasculostatin, a proteolytic fragment of brain Angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor, inhibited migration of endothelial cells in vitro and dramatically reduced in vivo angiogenesis. |
Customer Reviews and Q&As |
|---|
|
There are currently no customer reviews or questions for vasculostatin-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-vasculostatin (CyOV-0008XY). Click the button below to contact us or submit your feedback about this product. |
All products and services are for Research Use Only. Not For Clinical Use.
Other products
- IL-2-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP34.5, ΔΔICP47), hTERT-IL-2 (CAT#: CyOV-0139XY)
- MMP9-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-MMP9 (CAT#: CyOV-0119XY)
- IL-2-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-IL-2 (CAT#: CyOV-0125XY)
- CCL17-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-CCL17 (CAT#: CyOV-0001XY)
- CCL17-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP6, ΔΔICP34.5), CMV-CCL17 (CAT#: CyOV-0029XY)
- ING4-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), CMV-ING4 (CAT#: CyOV-0048XY)
- luciferase-encoding Oncolytic Herpes Simplex Virus 2 (ΔRL), IE4/5-luciferase (CAT#: RepOV-0155XY)
- IL-4-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-IL-4 (CAT#: CyOV-0126XY)
PRODUCTS
Online Inquiry